Clinical Roundup Should lowest-risk prostate cancer still be called “cancer”? UCLA-led study suggests changing the name could save lives July 10, 2026Vol.52 No.27
Clinical Roundup Equal access to cancer care removes race as predictor of survival, VA analysis finds July 10, 2026Vol.52 No.27
Clinical Roundup Sexual orientation, gender identity are key variables in cancer screening disparities, OSUCCC – James study finds July 10, 2026Vol.52 No.27
Clinical Roundup Tumor-on-a-chip model shows how pancreatic cancer hijacks immune cells, UMiami study finds July 10, 2026Vol.52 No.27
Clinical Roundup Cancer Research UK and partners announce new global phase II study in rare adrenal gland cancer July 10, 2026Vol.52 No.27
Drugs & Targets European Commission grants marketing authorization for Tepkinly + R2 in R/R FL July 10, 2026Vol.52 No.27
Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers noteOne woman’s pregnancy shows how this distinction matters July 02, 2026Vol.52 No.26By Claire Marie Porter
Cancer Policy AACR urges OMB to retract proposed rule on federally funded research July 02, 2026Vol.52 No.26By Sara Willa Ernst
Cancer Policy Visa delays continue as residency programs begin July 02, 2026Vol.52 No.26By Sara Willa Ernst
